News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
279,557 Results
Type
Article (14997)
Company Profile (281)
Press Release (264279)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (81656)
Career Advice (167)
Deals (13697)
Drug Delivery (36)
Drug Development (51552)
Employer Resources (31)
FDA (6248)
Job Trends (5381)
News (149238)
Policy (10985)
Tag
Academia (951)
Accelerated approval (2)
Adcomms (13)
Allergies (55)
Alliances (22201)
ALS (68)
Alzheimer's disease (873)
Antibody-drug conjugate (ADC) (108)
Approvals (6271)
Artificial intelligence (135)
Autoimmune disease (19)
Automation (5)
Bankruptcy (133)
Best Places to Work (4780)
BIOSECURE Act (6)
Biosimilars (47)
Biotechnology (232)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (163)
Cancer (1526)
Cardiovascular disease (121)
Career advice (148)
Career pathing (2)
CAR-T (121)
Cell therapy (337)
Cervical cancer (9)
Clinical research (42140)
Collaboration (568)
Compensation (280)
Complete response letters (13)
COVID-19 (1093)
CRISPR (44)
C-suite (172)
Cystic fibrosis (77)
Data (1629)
Denatured (11)
Depression (34)
Diabetes (148)
Diagnostics (1343)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (86)
Drug pricing (34)
Drug shortages (3)
Duchenne muscular dystrophy (91)
Earnings (31114)
Editorial (22)
Employer branding (4)
Employer resources (29)
Events (49862)
Executive appointments (478)
FDA (7043)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (516)
Gene editing (102)
Generative AI (10)
Gene therapy (261)
GLP-1 (376)
Government (1192)
Grass and pollen (2)
Guidances (67)
Healthcare (7027)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (98)
Indications (21)
Infectious disease (1160)
Inflammatory bowel disease (122)
Inflation Reduction Act (9)
Influenza (20)
Intellectual property (70)
Interviews (21)
IPO (7483)
IRA (13)
Job creations (893)
Job search strategy (138)
Kidney cancer (7)
Labor market (8)
Layoffs (223)
Leadership (4)
Legal (1776)
Liver cancer (34)
Lung cancer (209)
Lymphoma (104)
Machine learning (5)
Management (7)
Manufacturing (149)
MASH (59)
Medical device (3087)
Medtech (3088)
Mergers & acquisitions (6550)
Metabolic disorders (411)
Multiple sclerosis (55)
NASH (13)
Neurodegenerative disease (71)
Neuropsychiatric disorders (25)
Neuroscience (1301)
NextGen: Class of 2025 (2158)
Non-profit (1021)
Now hiring (22)
Obesity (202)
Opinion (108)
Ovarian cancer (66)
Pain (74)
Pancreatic cancer (64)
Parkinson's disease (122)
Partnered (8)
Patents (142)
Patient recruitment (85)
Peanut (36)
People (26076)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14686)
Phase II (19453)
Phase III (12585)
Pipeline (934)
Policy (52)
Postmarket research (942)
Preclinical (6196)
Press Release (30)
Prostate cancer (63)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (298)
Real estate (1460)
Recruiting (12)
Regulatory (9172)
Reports (16)
Research institute (963)
Resumes & cover letters (18)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (62)
Series A (100)
Series B (66)
Service/supplier (1)
Sickle cell disease (42)
Special edition (12)
Spinal muscular atrophy (118)
Sponsored (12)
Startups (2009)
State (1)
Stomach cancer (4)
Supply chain (25)
Tariffs (15)
The Weekly (37)
Vaccines (221)
Venture capitalists (32)
Weight loss (114)
Women's health (15)
Worklife (3)
Date
Last 7 days (563)
Last 30 days (1755)
Last 365 days (19753)
2025 (7088)
2024 (21114)
2023 (22948)
2022 (27554)
2021 (28654)
2020 (24401)
2019 (17033)
2018 (12512)
2017 (14288)
2016 (12355)
2015 (14972)
2014 (10857)
2013 (7869)
2012 (7935)
2011 (8042)
2010 (7808)
Location
Africa (167)
Alabama (43)
Alaska (2)
Arizona (60)
Arkansas (6)
Asia (17776)
Australia (3035)
California (4163)
Canada (1197)
China (372)
Colorado (153)
Connecticut (154)
Delaware (114)
Europe (38334)
Florida (519)
Georgia (130)
Idaho (17)
Illinois (246)
India (10)
Indiana (102)
Iowa (2)
Japan (78)
Kansas (66)
Kentucky (6)
Louisiana (3)
Maine (12)
Maryland (501)
Massachusetts (3234)
Michigan (74)
Minnesota (162)
Mississippi (1)
Missouri (25)
Montana (14)
Nebraska (4)
Nevada (19)
New Hampshire (14)
New Jersey (1064)
New Mexico (12)
New York (1097)
North Carolina (593)
North Dakota (5)
Northern California (1834)
Ohio (125)
Oklahoma (9)
Oregon (21)
Pennsylvania (771)
Puerto Rico (7)
Rhode Island (19)
South America (232)
South Carolina (5)
Southern California (1615)
Tennessee (27)
Texas (501)
United States (14199)
Utah (59)
Virginia (84)
Washington D.C. (32)
Washington State (361)
West Virginia (1)
Wisconsin (18)
279,557 Results for "relief therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update
April 10, 2025
·
2 min read
Press Releases
Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion
March 6, 2025
·
3 min read
Press Releases
Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief
May 6, 2025
·
4 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
Press Releases
Relief Therapeutics Provides Update on Potential Transaction with Renexxion
December 27, 2024
·
5 min read
Press Releases
Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011
February 11, 2025
·
4 min read
Business
Relief Therapeutics Announces Executive Changes - June 4, 2024
RELIEF THERAPEUTICS Holding SA today announced that interim Chief Executive Officer Michelle Lock has completed her transitional mandate with the Company.
June 3, 2024
·
2 min read
Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders
RELIEF THERAPEUTICS Holding SA announced the Annual General Meeting of shareholders will take place on Thursday, June 27, 2024, at 11:00 a.m. CEST at Campus Biotech, chemin des Mines 9, 1202 Geneva, Switzerland.
May 30, 2024
·
3 min read
Business
Relief Therapeutics has Published its Annual Report
RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, published its Annual Report 2023 and provided a corporate update.
April 30, 2024
·
2 min read
Press Releases
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
December 16, 2024
·
6 min read
1 of 27,956
Next
